510(k) K232522
K232522 is an FDA 510(k) premarket notification submitted by Ark Diagnostics, Inc. for the device "ARK Levetiracetam II Assay". The FDA issued a decision of Substantially Equivalent on February 27, 2024. The device falls under product code ORI (Levetiracetam Assay), a Class II device regulated under 21 CFR 862.3350. Ark Diagnostics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 27, 2024
- Date Received
- August 18, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Levetiracetam Assay
- Device Class
- Class II
- Regulation Number
- 862.3350
- Review Panel
- TX
- Submission Type
For the quantitative determination of levetiracetam in human serum or plasma.